Royal Bank of Canada
AMED

Royal Bank of Canada’s Amedisys AMED Stock Holding History

Royal Bank of Canada’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,000
Closed -$8.47M – 7445
2021
Q1 		$8.47M Buy
+32,000
New +$9.02M ﹤0.01% 1867

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's AMED Position: Q3 2025 in Review

Royal Bank of Canada sold out of Amedisys (AMED) in Q3 2025, closing a stake of 187,627 shares — an estimated $18.5M sold.

Royal Bank of Canada first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $18.5M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Royal Bank of Canada reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 187,627 Amedisys shares in Q3 2025, an estimated $18.5M.
  • Royal Bank of Canada first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Royal Bank of Canada's Amedisys position peaked at $18.5M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.